| Serial Number | 79115016 |
| Word Mark | MOLECULAR CRO |
| Filing Date | Friday, February 10, 2012 |
| Status | 402 - IR CANCELLED - US APPLICATION ABANDONED |
| Status Date | Thursday, February 10, 2022 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | professional business consultation and business organization consultation in the market authorization of medicines and medical devices; planning and conducting of trade fairs for economic or advertising purposes; import-export agencies in the field of medicines and medical devices; wholesale store services and retail store services featuring medicines; business marketing services related to medicines and medical devices; commercial information and advice for consumers; wholesale store services in the chemical products sector; market reports and studies |
| Goods and Services | medical services; veterinary services; hygienic and beauty care; medical diagnostic testing, monitoring and reporting services in preclinical and clinical settings; veterinary specialty services providing advanced medical and diagnostic services for animals; medical services, namely, medical and clinical examinations |
| Disclaimer with Predetermined Text | "CRO" |
| Goods and Services | scientific and technological services, namely, scientific research, analysis and testing in the field of medicine, genetics and medical biomarkers; testing, analysis, and evaluation of medical diagnostic and biomarker preparations to assure compliance with industry standards; industrial chemical, biochemical, biological and bacteriological research and analysis; medical and scientific research information in the field of medicine, genetics and medical biomarkers; research and development of vaccines and medicines; design and testing for new product development, namely, pharmaceutical and diagnostic preparations and substances; development of pharmaceutical preparations and medicines; research and development of vaccines and medicines; testing, analyzing and evaluating new medicines; chemical research laboratories, pharmaceutical research laboratories, medical research laboratories, bacteriology research laboratories, molecular biological/biological research laboratories; medical and scientific research, namely, conducting clinical trials for others; scientific analyses in the field of chemistry, biology, molecular biology, pharmaceutics, and food technology; computer development of software in the field of the operation of therapeutic and diagnostic equipment and for the data processing for the purpose of imaging; scientific and technological services, namely, scientific research particular in the field of chemistry, genetics, biology, bioengineering, and biochemistry; chemical, biochemical, biological and bacteriological research and analysis; DNA and RNA analysis services, namely, development and research of DNA, RNA and scientific research in the field of biochemistry and biotechnology; scientific research; preparation of scientific opinions in the field of scientific research and development; advisory services relating to biotechnology, pharmaceutical research and development and genetic science; medical and scientific research, namely, the extraction or cultivation, scientific processing, and scientific analysis of biomaterials and compiling data for research purposes in the filed of medical science and medical consultancy; contract research in the field of pharmacological and clinical development of medicines; scientific data analysis for scientific and technical purposes, namely analysis of data originating from clinical trials; scientific laboratory services, namely, scientific development, research, identification, validation, analysis and interpretation of biomarkers, particularly nucleic acid based biomarkers |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | H - NOT AVAILABLE |
| Class Status Date | Thursday, February 10, 2022 |
| Primary Code | 035 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | H - NOT AVAILABLE |
| Class Status Date | Thursday, February 10, 2022 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | H - NOT AVAILABLE |
| Class Status Date | Thursday, February 10, 2022 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Comprehensive Biomarker Center GmbH |
| Party Type | 11 - New Owner Before Publication |
| Legal Entity Type | 98 - Unknown |
| Address | DE |
| Party Name | febit holding GmbH |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | DE |
| Event Date | Event Description |
| Sunday, September 4, 2022 | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED |
| Saturday, September 3, 2022 | DEATH OF INTERNATIONAL REGISTRATION |
| Thursday, June 9, 2016 | NEW REPRESENTATIVE AT IB RECEIVED |
| Thursday, October 23, 2014 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Tuesday, October 7, 2014 | FINAL DISPOSITION NOTICE SENT TO IB |
| Tuesday, October 7, 2014 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Thursday, May 8, 2014 | CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED |
| Thursday, April 24, 2014 | CORRECTION TRANSACTION RECEIVED FROM IB |
| Friday, January 24, 2014 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
| Wednesday, January 8, 2014 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Wednesday, January 8, 2014 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
| Monday, December 23, 2013 | CHANGE OF OWNER RECEIVED FROM IB |
| Monday, October 7, 2013 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND |
| Monday, October 7, 2013 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Friday, February 22, 2013 | FINAL REFUSAL MAILED |
| Friday, February 22, 2013 | FINAL REFUSAL WRITTEN |
| Thursday, February 7, 2013 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, February 6, 2013 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, February 6, 2013 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, August 30, 2012 | REFUSAL PROCESSED BY IB |
| Thursday, August 9, 2012 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Thursday, August 9, 2012 | REFUSAL PROCESSED BY MPU |
| Thursday, August 9, 2012 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Wednesday, August 8, 2012 | NON-FINAL ACTION WRITTEN |
| Tuesday, August 7, 2012 | APPLICATION FILING RECEIPT MAILED |
| Friday, August 3, 2012 | ASSIGNED TO EXAMINER |
| Friday, August 3, 2012 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Thursday, August 2, 2012 | SN ASSIGNED FOR SECT 66A APPL FROM IB |